Stock Detail
Videos
Dyadic Applied BioSolutions (DYAI) Company Webcast
Dyadic Applied BioSolutions (NASDAQ: DYAI) is focused on leveraging advanced microbial and protein expression technologies to support the development and manufacture of biopharmaceuticals, vaccines, and other biologic products. The company's proprietary technology...
Dyadic Applied BioSolutions (DYAI) Fireside Chat
Dyadic Applied BioSolutions (Nasdaq: DYAI) is a global biotechnology company that uses its proprietary microbial platforms to produce recombinant proteins that are sold or licensed to partners across the life sciences, food and nutrition, and bio-industrial markets....
Dyadic International (DYAI) Fireside Chat
For this fireside chat, we welcome Dyadic, Inc., which trades on the NASDAQ under the ticker DYAI. Joining us from the company is Mark Emalfarb, Chief Executive Officer. Dyadic International, Inc. (NASDAQ: DYAI) is a global biotechnology company focused on building...
News
Dyadic Highlights Accelerated Interest in C1 Biomanufacturing Platform Amid Ebola Preparedness Activities and Growing Commercial Adoption
Company's C1 platform may help address urgent need for rapid, scalable vaccine and antibody manufacturing while supporting broader commercialization across life sciences, food, nutrition and industrial marketsJUPITER, Fla., June 15, 2026 (GLOBE NEWSWIRE) -- Dyadic...
Dyadic and Scripps Research Collaborate on Rapid-Response Hantavirus Antibody and Vaccine Development
Collaboration Leverages Prior Andes, Marburg and Ebola Virus Research and Dyadic's C1 Platform Capabilities for Fast, Scalable Biologic ProductionJUPITER, Fla., May 28, 2026 (GLOBE NEWSWIRE) -- Dyadic International, Inc. ("Dyadic," "we," "us," "our," or the "Company")...
Dyadic to Participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026
JUPITER, Fla., May 21, 2026 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), d/b/a Dyadic Applied BioSolutions, a global biotechnology company...



